A case of ROS1‐rearranged lung adenocarcinoma exhibiting pleural effusion caused by crizotinib

A case of ROS1‐rearranged lung adenocarcinoma exhibiting pleural effusion caused by crizotinib

Reports of crizotinib‐induced pleural effusion in non‐small cell lung cancer (NSCLC) are limited. A 35‐year‐old Japanese woman was diagnosed with ROS1‐rearranged lung adenocarcinoma (primary left lower lobe, cT4N3M1c). Crizotinib was administered as first‐line therapy, and the primary and mediastina...

Full description

Bibliographic Details
Main Authors: Hiroaki Tachi, Kengo Nishino, Taisuke Nakaizumi, Kenya Kuramoto, Kei Shimizu, Yusuke Yamamoto, Keisuke Kobayashi, Hideo Ichimura, Akiko Sakata, Takeshi Nawa
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:Thoracic Cancer
Subjects:
Complete response
crizotinib
lung adenocarcinoma
pleural effusion
ROS1 rearrangement
Online Access:https://doi.org/10.1111/1759-7714.13496

Internet

https://doi.org/10.1111/1759-7714.13496

Similar Items